Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Clonal expansions of 6-thioguanine resistant T lymphocytes in the blood and tumor of melanoma patients.

Albertini MR, Macklin MD, Zuleger CL, Newton MA, Judice SA, Albertini RJ.

Environ Mol Mutagen. 2008 Dec;49(9):676-87. doi: 10.1002/em.20417.

2.

In vivo 6-thioguanine-resistant T cells from melanoma patients have public TCR and share TCR beta amino acid sequences with melanoma-reactive T cells.

Zuleger CL, Macklin MD, Bostwick BL, Pei Q, Newton MA, Albertini MR.

J Immunol Methods. 2011 Feb 28;365(1-2):76-86. doi: 10.1016/j.jim.2010.12.007. Epub 2010 Dec 21.

3.

In vivo mutant frequency of thioguanine-resistant T-cells in the peripheral blood and lymph nodes of melanoma patients.

Albertini MR, King DM, Newton MA, Vacek PM.

Mutat Res. 2001 May 9;476(1-2):83-97.

PMID:
11336986
4.
5.

High frequency of T cell clonal expansions in primary human melanoma. Involvement of a dominant clonotype in autologous tumor recognition.

Pisarra P, Mortarini R, Salvi S, Anichini A, Parmiani G, Sensi M.

Cancer Immunol Immunother. 1999 Apr;48(1):39-46.

PMID:
10235487
6.

T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood.

Albertini RJ, Castle KL, Borcherding WR.

Proc Natl Acad Sci U S A. 1982 Nov;79(21):6617-21.

7.

The effect of T-lymphocyte 'clonality' on the calculated hprt mutation frequency occurring in vivo in humans.

O'Neill JP, Nicklas JA, Hunter TC, Batson OB, Allegretta M, Falta MT, Branda RF, Albertini RJ.

Mutat Res. 1994 Oct-Dec;313(2-3):215-25.

PMID:
7523907
9.

Coamplification of hprt cDNA and gamma T-cell receptor sequences from 6-thioguanine resistant human T-lymphocytes.

Curry J, Skandalis A, Holcroft J, de Boer J, Glickman B.

Mutat Res. 1993 Aug;288(2):269-75.

PMID:
7688087
10.

Heterogeneity of T-cell clones infiltrating primary malignant melanomas.

Yazdi AS, Morstedt K, Puchta U, Ghoreschi K, Flaig MJ, Rocken M, Sander CA.

J Invest Dermatol. 2006 Feb;126(2):393-8.

11.
12.

Southern-blot analyses of human T-lymphocyte mutants induced in vitro by gamma-irradiation.

O'Neill JP, Hunter TC, Sullivan LM, Nicklas JA, Albertini RJ.

Mutat Res. 1990 Feb;240(2):143-9.

PMID:
2153929
13.
14.

Molecular analyses of in vivo hprt mutations in human T-lymphocytes: IV. Studies in newborns.

McGinniss MJ, Nicklas JA, Albertini RJ.

Environ Mol Mutagen. 1989;14(4):229-37.

PMID:
2583130
15.

Alterations of the hprt gene in human in vivo-derived 6-thioguanine-resistant T lymphocytes.

Albertini RJ, O'Neill JP, Nicklas JA, Heintz NH, Kelleher PC.

Nature. 1985 Jul 25-31;316(6026):369-71.

PMID:
2991767
16.

Analysis of T cell receptor beta and gamma genes from peripheral blood, regional lymph node and tumor-infiltrating lymphocyte clones from melanoma patients.

Albertini MR, Nicklas JA, Chastenay BF, Hunter TC, Albertini RJ, Clark SS, Hank JA, Sondel PM.

Cancer Immunol Immunother. 1991;32(5):325-30.

PMID:
1825620
17.

Hprt activities and RNA phenotypes in 6-thioguanine resistant human T-lymphocytes.

Steen AM, Sahlén S, Hou SM, Lambert B.

Mutat Res. 1993 Apr;286(2):209-15.

PMID:
7681532
18.
19.

In vitro induction, expression and selection of thioguanine-resistant mutants with human T-lymphocytes.

O'Neill JP, Sullivan LM, Albertini RJ.

Mutat Res. 1990 Feb;240(2):135-42.

PMID:
2300074
20.

Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope.

Cole DJ, Weil DP, Shamamian P, Rivoltini L, Kawakami Y, Topalian S, Jennings C, Eliyahu S, Rosenberg SA, Nishimura MI.

Cancer Res. 1994 Oct 15;54(20):5265-8. Erratum in: Cancer Res 1994 Nov 15;54(22):6014.

Supplemental Content

Support Center